Torres VE (2001) Polycystic kidney disease autosomal-dominant and recessive forms. In: Massry SG, Glassock RJ (eds) Textbook of nephrology, 4th edn. Lippincott Williams & Wilkins, Philadelphia, pp 896–904
Google Scholar
Gardner KD Jr, Evan AP (1984) Cystic kidneys: an enigma evolves. Am J Kidney Dis 3(6):403–413
PubMed
Article
Google Scholar
Schwab SJ, Bander SJ, Klahr S (1987) Renal infection in autosomal dominant polycystic kidney disease. Am J Med 82(4):714–718
CAS
PubMed
Article
Google Scholar
Chapman AB, Thickman D, Gabow PA (1990) Percutaneous cyst puncture in the treatment of cyst infection in autosomal dominant polycystic kidney disease. Am J Kidney Dis 16(3):252–255
CAS
PubMed
Article
Google Scholar
Harris PC, Torres VE (2011) Autosomal dominant polycystic kidney disease. GeneReviews® [Internet], http://www.ncbi.nlm.nih.gov/books/NBK1246/. Last Updated 8 Dec. 2011
Suwabe T, Ubara Y, Sumida K, Hayami N, Hiramatsu R, Yamanouchi M, Hasegawa E, Hoshino J, Sawa N, Saitoh S, Okuda I, Takaichi K (2012) Clinical features of cyst infection and hemorrhage in ADPKD: new diagnostic criteria. Clin Exp Nephrol 16(6):892–902
CAS
PubMed
Article
Google Scholar
Muther RS, Bennett WM (1981) Cyst fluid antibiotic concentrations in polycystic kidney disease: differences between proximal and distal cysts. Kidney Int 20(4):519–522
CAS
PubMed
Article
Google Scholar
Bennett WM, Elzinga L, Pulliam JP, Rashad AL, Barry JM (1985) Cyst fluid antibiotic concentrations in autosomal-dominant polycystic kidney disease. Am J Kidney Dis 6(6):400–404
CAS
PubMed
Article
Google Scholar
Schwab S, Hinthorn D, Diederich D, Cuppage F, Grantham J (1983) pH-dependent accumulation of clindamycin in a polycystic kidney. Am J Kidney Dis 3(1):63–66
CAS
PubMed
Article
Google Scholar
Elzinga LW, Golper TA, Rashad AL, Carr ME, Bennett WM (1987) Trimethoprim–sulfamethoxazole in cyst fluid from autosomal dominant polycystic kidneys. Kidney Int 32(6):884–888
CAS
PubMed
Article
Google Scholar
Elzinga LW, Golper TA, Rashad AL, Carr ME, Bennett WM (1988) Ciprofloxacin activity in cyst fluid from polycystic kidneys. Antimicrob Agents Chemother 32(6):844–847
CAS
PubMed Central
PubMed
Article
Google Scholar
Rossi SJ, Healy DP, Savani DV, Deepe G (1993) High-dose ciprofloxacin in the treatment of a renal cyst infection. Ann Pharmacother 27(1):38–39
CAS
PubMed
Google Scholar
Hiyama L, Tang A, Miller LG (2006) Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease. Am J Kidney Dis 47(1):e9–e13
PubMed
Article
Google Scholar
Schwab SJ, Weaver ME (1986) Penetration of trimethoprim and sulfamethoxazole into cysts in a patient with autosomal-dominant polycystic kidney disease. Am J Kidney Dis 7(5):434–438
CAS
PubMed
Article
Google Scholar
Suwabe T, Ubara Y, Higa Y, Nakanishi S, Sogawa Y, Nomura K, Nishimura H, Hoshino J, Sawa N, Katori H, Takemoto F, Nakamura M, Tomikawa S, Hara S, Takaichi K (2009) Infected hepatic and renal cysts: differential impact on outcome in autosomal dominant polycystic kidney disease. Nephron Clin Pract 112(3):c157–c163
CAS
PubMed
Article
Google Scholar
Sallée M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, Fakhouri F (2009) Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 4(7):1183–1189
PubMed Central
PubMed
Article
Google Scholar
Jouret F, Lhommel R, Devuyst O, Annet L, Pirson Y, Hassoun Z, Kanaan N (2012) Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities. Nephrol Dial Transplant 27(10):3746–3751
CAS
PubMed
Article
Google Scholar
Truven Health Analytics, Inc. (2014) Dosing information: dosage in renal failure. DRUGDEX®
Jouret F, Lhommel R, Beguin C, Devuyst O, Pirson Y, Hassoun Z, Kanaan N (2011) Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 6(7):1644–1650
PubMed
Article
Google Scholar
Lu PL, Liu YC, Toh HS, Lee YL, Liu YM, Ho CM, Huang CC, Liu CE, Ko WC, Wang JH, Tang HJ, Yu KW, Chen YS, Chuang YC, Xu Y, Ni Y, Chen YH, Hsueh PR (2012) Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). Int J Antimicrob Agents 40(Suppl):S37–S43
CAS
PubMed
Article
Google Scholar
Fissell RB, Fuller DS, Morgenstern H, Gillespie BW, Mendelssohn DC, Rayner HC, Robinson BM, Schatell D, Kawanishi H, Pisoni RL (2013) Hemodialysis patient preference for type of vascular access: variation and predictors across countries in the DOPPS. J Vasc Access 14(3):264–272
PubMed
Article
Google Scholar
Ravani P, Gillespie BW, Quinn RR, MacRae J, Manns B, Mendelssohn D, Tonelli M, Hemmelgarn B, James M, Pannu N, Robinson BM, Zhang X, Pisoni R (2013) Temporal risk profile for infectious and noninfectious complications of hemodialysis access. J Am Soc Nephrol 24(10):1668–1677
PubMed Central
PubMed
Article
Google Scholar
Matsumoto T, Hamasuna R, Ishikawa K, Takahashi S, Yasuda M, Hayami H, Tanaka K, Kiyota H, Muratani T, Monden K, Arakawa S, Yamamoto S (2011) Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan (2008). Int J Antimicrob Agents 37(3):210–218
CAS
PubMed
Article
Google Scholar
Chapman AB, Rahbari-Oskoui FF, Bennett WM (2014) Urinary tract infection in autosomal dominant polycystic kidney disease. UpToDate®. Last Updated 3 Dec. 2014